Altamira Therapeutics
CYTO
#10197
Rank
HK$11.89 M
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
HK$3.15
Share price
-4.28%
Change (1 day)
-88.75%
Change (1 year)

EPS for Altamira Therapeutics (CYTO)

EPS in 2019 (TTM): -HK$2,414

According to Altamira Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$2,393. In 2018 the company made an earnings per share (EPS) of -HK$3,370 an increase over its 2017 EPS that were of -HK$18,212.

EPS history for Altamira Therapeutics from 2013 to 2019

Annual EPS

Year EPS Change
2019 (TTM)-HK$2,414-28.36%
2018-HK$3,370-81.5%
2017-HK$18,212-36.52%
2016-HK$28,690-5.17%
2015-HK$30,2527.77%
2014-HK$28,0700.33%
2013-HK$27,977